Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Prime Medicine (PRME) FCF Margin (2024 - 2025)

Prime Medicine (PRME) has disclosed FCF Margin for 2 consecutive years, with 4480.43% as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, FCF Margin fell 489555.0% year-over-year to 4480.43%, compared with a TTM value of 3607.41% through Dec 2025, up 75595.0%, and an annual FY2025 reading of 3607.41%, up 75595.0% over the prior year.
  • FCF Margin was 4480.43% for Q4 2025 at Prime Medicine, down from 3194.45% in the prior quarter.
  • Across five years, FCF Margin topped out at 415.12% in Q4 2024 and bottomed at 12281.34% in Q3 2024.